Alburx Solution
NDC Package 44206-310-11

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Alburx (albumin (human)) solution is the use of AlbuRx® 5, Albumin (Human) 5% solution is contraindicated in patients with a history of an incompatibility reaction to such preparations (see ADVERSE REACTIONS). This formulation utilizes a solution delivery system. Marketed by Csl Behring Ag, this product is identified by NDC 44206-310 and is authorized under FDA application BLA102366.

Identification & Billing

NDC Package Code
44206-310-11
Package Description
1 VIAL, GLASS in 1 CARTON / 50 mL in 1 VIAL, GLASS
Product Code
44206-310
11-Digit Billing Format
44206031011
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Alburx
Non-Proprietary Name
Albumin (human)
Substance Name
Albumin Human
Dosage Form
Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
Administration Route
Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
ALBUMIN HUMAN 12.5 g/250mL
Pharmacologic Class
Usage Information
The use of AlbuRx® 5, Albumin (Human) 5% solution is contraindicated in patients with a history of an incompatibility reaction to such preparations (see ADVERSE REACTIONS). In addition, AlbuRx® 5 may be contraindicated in patients with cardiac failure or severe anemia because of the risk of acute circulatory overload.

Regulatory & Marketing

Labeler Name
Csl Behring Ag
Product Type
Plasma Derivative
FDA Application #
BLA102366
Marketing Category
BLA - A product marketed under an approved Biologic License Application.
Start Marketing Date
01-06-2009
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (44206-310). Click a package code to view its specific billing and regulatory data.

44206-310-25
1 VIAL, GLASS in 1 CARTON / 250 mL in 1 VIAL, GLASS (44206-310-90)
44206-310-50
1 VIAL, GLASS in 1 CARTON / 500 mL in 1 VIAL, GLASS (44206-310-91)

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 44206-310-11 identifies a specific commercial package of 1 vial, glass in 1 carton / 50 ml in 1 vial, glass of Alburx, a plasma derivative labeled by Csl Behring Ag. This solution is formulated for intravenous use and contains albumin human as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Csl Behring Ag on January 06, 2009. The current certification is valid through December 31, 2026.

How is this Csl Behring Ag product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 44206031011. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
44206-310-11
11-Digit CMS (5-4-2)
44206-0310-11

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.